Prior Stephen David
Chief Strategy Officer
Prior Stephen David has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jan 7, 2026.
On the most recent filing, Prior Stephen David is listed as Chief Strategy Officer at AN2 Therapeutics, Inc. Inside the rolling window, Prior Stephen David reported no open-market purchases and 3 open-market sales totaling $7K in ANTX. The largest disclosed transaction in the window is a sale of 3,604 ANTX shares on Jan 5, 2026, worth $4K.
Companies traded
Other insiders at ANTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Prior Stephen David made?
Prior Stephen David has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Prior Stephen David trade?
Prior Stephen David has filed SEC Form 4 disclosures for 1 company, including ANTX.
When was Prior Stephen David's most recent SEC Form 4 filing?
Prior Stephen David's most recent SEC Form 4 filing on Tracefour is dated Jan 7, 2026.
What is Prior Stephen David's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Prior Stephen David is listed as Chief Strategy Officer.
What is Prior Stephen David's total buy and sell value in the current window?
Inside the rolling retention window, Prior Stephen David bought $0 and sold $7K based on SEC Form 4 filings.
What was Prior Stephen David's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,604 ANTX shares on 2026-01-05, worth $4K, per SEC Form 4 filings.